This page shows the latest ulcerative colitis news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly’s IL-23 blocker mirikizumab has hit the mark in a phase 3 study in ulcerative colitis (UC), helping patients to achieve clinical remission 12 weeks after initiating treatment. ... Skyrizi is also being evaluated in a phase 2/3 trial for
the potential treatment of ulcerative colitis and other autoimmune diseases. ... of systemic lupus erythematosus and ulcerative colitis.
It is also approved to treat patients with psoriatic arthritis who have not responded well to prior methotrexate treatment and ulcerative colitis.
ABX464 has previously demonstrated efficacy in a phase 2a trial in the severe inflammatory disease ulcerative colitis (UC), in which the drug produced potent anti-inflammatory effects and tissue healing.
French biotech company Abivax is also currently investigating its experimental ulcerative colitis drug ABX464 as an early treatment for elderly or high-risk patients with COVID-19.
ABX464 has previously demonstrated efficacy in a phase 2a trial in the severe inflammatory disease ulcerative colitis (UC), in which the drug produced potent anti-inflammatory effects and tissue healing.
More from news
Approximately 22 fully matching, plus 125 partially matching documents found.
With a focus on inflammatory and fibrotic conditions, we have submitted a marketing application through our partnership with Gilead for a new treatment for ulcerative colitis (UC) to the MHRA in
with Crohn’s disease or ulcerative colitis is expected to rise by around 25% by 2025, according to recent studies.
These capabilities attract collaborations with leading groups from around the world to provide the clinical data and samples to feed the process, including a University of Adelaide ulcerative colitis FMT study. ... We know this has had an impact.
ulcerative colitis, type 1 diabetes and inflammatory bowel disease.
Personalisation: A case study. This case study is of a digital health support programme that improved persistence of people with ulcerative colitis.
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Atlantic's lead asset, alicaforsen for the treatment of the inflammatory bowel diseases ulcerative colitis and pouchitis.
Its lead product candidate is bertilimumab, which is in clinical development for ulcerative colitis and Crohn's Disease as well as the rare skin condition bullous pemphigoid.
Will lead the development of AVX-470 in ulcerative colitis. Former AstraZeneca (AZ) vice president Dr Deborah Hartman has joined Avaxia Biologics as VP research, replacing Dan Tracey who retires. ... with active ulcerative colitis.
Their respective alternates are Kirsten Myhr, from the Norwegian Board of Health, and Marco Greco, from the European Federation Crohn's and Ulcerative Colitis Associations.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
We carried out a survey among patients who have any one of these conditions: chronic obstructive pulmonary disorder (COPD), ulcerative colitis (UC), Crohn’s disease (CD) and idiopathic pulmonary fibrosis (IPF).
Although there’s been an increase of inflammatory bowel disease (IBD) in underrepresented populations, there are still lots of misconceptions surrounding Crohn’s and ulcerative colitis among certain ethnic groups. ... Different ethnic groups are at
Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.
The winning entry focused on exploring the Crohn’s Disease and Ulcerative Colitis patient journeys – mapping the transactional touchpoints and overlaying the emotional experience of patients so that Janssen could gauge
Kate is experienced in a wide range of therapy areas, including immunology, specifically Crohn’s disease, ulcerative colitis and psoriatic arthritis, in ophthalmology, including retinal diseases, glaucoma and dry eye disease,
More from PMHub
Approximately 5 fully matching, plus 10 partially matching documents found.
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...